Radiosensitizing effect of 5-aminolevulinic acid and protoporphyrin IX on carbon-ion beam irradiation

14Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Background/Aim: Carbon-ion beam is one of the most advanced radiations used for cancer treatment. However, there are tumors that are difficult to suppress with carbon-ion beam alone, thus necessitating development of drugs that can enhance its therapeutic effect. In this regard, the radiosensitizing effect of 5-aminolevulinic acid (ALA) and protoporphyrin IX (PpIX), that is a metabolic intermediate of ALA, on carbon-ion beam was investigated. Materials and Methods: Radiosensitizing activity, mitochondrial ROS and DNA double-strand break production of ALA and PpIX were evaluated by irradiation with 1.0 or 1.5-Gy carbon-ion beam to mouse mammary EMT6 tumor cells. Results: Combination of carbon-ion beam and ALA or PpIX showed a significant enhancement of its cytotoxic activity through a significant increase in ROS production in mitochondria. Furthermore, the combined activity of carbon-ion beam and ALA resulted in a significant increase in DNA double-strand breakage. Conclusion: ALA selectively accumulates in the mitochondria and PpIX synthesized from ALA reacts with carbon-ion beam to produce ROS that exert antitumor activity.

Cite

CITATION STYLE

APA

Kaneko, T., Tominaga, M., Kouzaki, R., Hanyu, A., Ueshima, K., Yamada, H., … Uto, Y. (2018). Radiosensitizing effect of 5-aminolevulinic acid and protoporphyrin IX on carbon-ion beam irradiation. In Anticancer Research (Vol. 38, pp. 4313–4317). International Institute of Anticancer Research. https://doi.org/10.21873/anticanres.12730

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free